Skip to main content
Top
Published in: Surgery Today 2/2014

01-02-2014 | Case Report

Photodynamic detection and management of intraperitoneal spreading of primary peritoneal papillary serous carcinoma in a man: report of a case

Authors: Emel Canbay, Haruaki Ishibashi, Shouzou Sako, Toshiyuki Kitai, Eisei Nishino, Masamitsu Hirano, Akiyoshi Mizumoto, Yoshio Endo, Shun-ichiro Ogura, Yutaka Yonemura

Published in: Surgery Today | Issue 2/2014

Login to get access

Abstract

As a peritoneal surface malignancy, primary peritoneal papillary serous carcinoma (PPPSC) almost always occurs in women. Our search of the literature found only two previous case reports of men with PPPSC, both with very short survival. We report the case of a 63-year-old man with PPPSC, treated effectively with cytoreductive surgery and docetaxel-based hyperthermic intraperitoneal chemotherapy following six cycles of docetaxel-based laparoscopic neoadjuvant intraperitoneal and cisplatin-based systemic chemotherapy. Furthermore, we detected intraoperative intraperitoneal spreading of the tumor after the oral administration of 5-amino levulinic acid (5-ALA). The patient remains in good health without ascites 18 months after his diagnosis. Thus, primary peritoneal papillary serous carcinoma should be managed by intraperitoneal chemotherapy combined with peritonectomy procedures. Moreover, the intraoperative detection of the intraperitoneal spreading of the tumor after administering oral 5-ALA shows that this is an exciting and promising diagnostic technique, which needs to be confirmed by further studies.
Literature
1.
go back to reference Muto MG, Welch WR, Mok SC, Bandera CA, Fishbaugh PM, Tsao SW, Lau CC, Goodman HM, Knapp RC, Berkowitz RS. Evidence for a multifocal origin of papillary serous carcinoma of the peritoneum. Cancer Res. 1995;55(3):490–2.PubMed Muto MG, Welch WR, Mok SC, Bandera CA, Fishbaugh PM, Tsao SW, Lau CC, Goodman HM, Knapp RC, Berkowitz RS. Evidence for a multifocal origin of papillary serous carcinoma of the peritoneum. Cancer Res. 1995;55(3):490–2.PubMed
2.
go back to reference Levy AD, Arnaiz J, Shaw JC, Sobin LH. Primary peritoneal tumors: imaging features with pathologic correlation. Radiographics. 2008;28:583–607.PubMedCrossRef Levy AD, Arnaiz J, Shaw JC, Sobin LH. Primary peritoneal tumors: imaging features with pathologic correlation. Radiographics. 2008;28:583–607.PubMedCrossRef
3.
go back to reference Schorge JO, Muto MG, Lee SJ, Huang LW, Welch WR, Bell DA, Keung EZ, Berkowitz RS, Mok SC. BRCA1-related papillary serous carcinoma of the peritoneum has a unique molecular pathogenesis. Cancer Res. 2000;60(5):1361–4.PubMed Schorge JO, Muto MG, Lee SJ, Huang LW, Welch WR, Bell DA, Keung EZ, Berkowitz RS, Mok SC. BRCA1-related papillary serous carcinoma of the peritoneum has a unique molecular pathogenesis. Cancer Res. 2000;60(5):1361–4.PubMed
4.
go back to reference Truong LD, Maccato ML, Awalt H, Cagle PT, Schwartz MR, Kaplan AL. Serous surface carcinoma of the peritoneum: a clinicopathologic study of 22 cases. Hum Pathol. 1990;21(1):99–110.PubMedCrossRef Truong LD, Maccato ML, Awalt H, Cagle PT, Schwartz MR, Kaplan AL. Serous surface carcinoma of the peritoneum: a clinicopathologic study of 22 cases. Hum Pathol. 1990;21(1):99–110.PubMedCrossRef
5.
go back to reference Shah IA, Jayram L, Gani OS, Fox IS, Stanley TM. Papillary serous carcinoma of the peritoneum in man. Cancer. 1998;82(5):860–6.PubMedCrossRef Shah IA, Jayram L, Gani OS, Fox IS, Stanley TM. Papillary serous carcinoma of the peritoneum in man. Cancer. 1998;82(5):860–6.PubMedCrossRef
6.
go back to reference Shmueli E, Leider-Trejo L, Schwartz I, Aderka D, Inbar M. Primary papillary serous carcinoma of the peritoneum in a man. Ann Oncol. 2001;12:563–7.PubMedCrossRef Shmueli E, Leider-Trejo L, Schwartz I, Aderka D, Inbar M. Primary papillary serous carcinoma of the peritoneum in a man. Ann Oncol. 2001;12:563–7.PubMedCrossRef
7.
go back to reference Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S, Mooney M, Rubinstein L, Shankar L, Dodd L, Kaplan R, Lacombe D, Verweij J. New response evaluation criteria in solid tumors:revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45:228–47.PubMedCrossRef Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S, Mooney M, Rubinstein L, Shankar L, Dodd L, Kaplan R, Lacombe D, Verweij J. New response evaluation criteria in solid tumors:revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45:228–47.PubMedCrossRef
9.
go back to reference Swerdlow M. Mesothelioma of the pelvic peritoneum resembling papillary cystadenocarcinoma of the ovary. Am J obstet Gynecol. 1959;77:197–200.PubMed Swerdlow M. Mesothelioma of the pelvic peritoneum resembling papillary cystadenocarcinoma of the ovary. Am J obstet Gynecol. 1959;77:197–200.PubMed
11.
go back to reference Lavazzo C, Vorgias G, Katsoulis M, Kalinoglou N, Dertimas V, Akrivos T. Primary peritoneal serous papillary carcinoma: clinical and laboratory characteristics. Arch Gynecol Obstet. 2008;278(1):53–6.CrossRef Lavazzo C, Vorgias G, Katsoulis M, Kalinoglou N, Dertimas V, Akrivos T. Primary peritoneal serous papillary carcinoma: clinical and laboratory characteristics. Arch Gynecol Obstet. 2008;278(1):53–6.CrossRef
12.
go back to reference Suh JH, Kim YH, Chang ED. Primary papillary serous carcinoma of the peritoneum diagnosed by video-assisted thoracoscopic surgery: report of a case. Surg Today. 2008;38(8):743–6.PubMedCrossRef Suh JH, Kim YH, Chang ED. Primary papillary serous carcinoma of the peritoneum diagnosed by video-assisted thoracoscopic surgery: report of a case. Surg Today. 2008;38(8):743–6.PubMedCrossRef
13.
go back to reference Zhang C, Li XP, Cui H, Shen DH, Wei LH. Advanced primary peritoneal carcinoma: clinicopathological and prognostic factor analyses. J Zhejiang Univ Sci B. 2008;9(6):435–40.PubMedCentralPubMedCrossRef Zhang C, Li XP, Cui H, Shen DH, Wei LH. Advanced primary peritoneal carcinoma: clinicopathological and prognostic factor analyses. J Zhejiang Univ Sci B. 2008;9(6):435–40.PubMedCentralPubMedCrossRef
14.
go back to reference Ajisaka H, Yonemura Y, Bando E, Fushida S, Nishimura G, Miwa K. Long-term survival of a patient with primary papillary serous carcinoma of the peritoneum treated by subtotal peritonectomy plus intraoperative chemohyperthermia. Hepatogastroenterology. 2002;49(46):1027–9.PubMed Ajisaka H, Yonemura Y, Bando E, Fushida S, Nishimura G, Miwa K. Long-term survival of a patient with primary papillary serous carcinoma of the peritoneum treated by subtotal peritonectomy plus intraoperative chemohyperthermia. Hepatogastroenterology. 2002;49(46):1027–9.PubMed
15.
go back to reference Barnetson RJ, Burnett RA, Downie A, Harper CM, Roberts F. Immunohistochemical analysis of peritoneal mesothelioma and primary and secondary serous carcinoma of the peritoneum. Am J Clin Pathol. 2006;125:67–76.PubMed Barnetson RJ, Burnett RA, Downie A, Harper CM, Roberts F. Immunohistochemical analysis of peritoneal mesothelioma and primary and secondary serous carcinoma of the peritoneum. Am J Clin Pathol. 2006;125:67–76.PubMed
16.
go back to reference Attanoos RL, Webb R, Dojcinov SD, Gibbs AR. Value of mesothelial and epithelial antibodies in distinguishing diffuse peritoneal mesothelioma in females from serous papillary carcinoma of the ovary and peritoneum. Histopathology. 2002;40:237–44.PubMedCrossRef Attanoos RL, Webb R, Dojcinov SD, Gibbs AR. Value of mesothelial and epithelial antibodies in distinguishing diffuse peritoneal mesothelioma in females from serous papillary carcinoma of the ovary and peritoneum. Histopathology. 2002;40:237–44.PubMedCrossRef
17.
go back to reference Bloos JD, Brady MF, Liao SY, Roceroto T, Partridge EE, Clarke-Pearson DL, Gynecologic Oncology Group Study. Extraovarian peritoneal serous papillary carcinoma: a phase II trial of cisplatin and cyclophosphamide with comparison to a cohort with papillary serous ovarian carcinoma. Gynecol Oncol. 2003;89(1):148–54.CrossRef Bloos JD, Brady MF, Liao SY, Roceroto T, Partridge EE, Clarke-Pearson DL, Gynecologic Oncology Group Study. Extraovarian peritoneal serous papillary carcinoma: a phase II trial of cisplatin and cyclophosphamide with comparison to a cohort with papillary serous ovarian carcinoma. Gynecol Oncol. 2003;89(1):148–54.CrossRef
18.
go back to reference Piver MS, Eltabbakh GH, Hempling RE, Recio FO, Blumenson LE. Two sequential studies for primary peritoneal carcinoma: induction with weekly cisplatin followed by either cisplatin doxorubicin-cyclophosphamide or paclitaxel-cisplatin. Gynecol Oncol. 1997;67(2):141–6.PubMedCrossRef Piver MS, Eltabbakh GH, Hempling RE, Recio FO, Blumenson LE. Two sequential studies for primary peritoneal carcinoma: induction with weekly cisplatin followed by either cisplatin doxorubicin-cyclophosphamide or paclitaxel-cisplatin. Gynecol Oncol. 1997;67(2):141–6.PubMedCrossRef
19.
go back to reference Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol. 2002;20(5):1248–59.PubMedCrossRef Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol. 2002;20(5):1248–59.PubMedCrossRef
20.
go back to reference Sugarbaker PH. Laboratory and clinical basis for hyperthermia as a component of intracavitary chemotherapy. Int J Hyperthermia. 2007;23:431–42.PubMedCrossRef Sugarbaker PH. Laboratory and clinical basis for hyperthermia as a component of intracavitary chemotherapy. Int J Hyperthermia. 2007;23:431–42.PubMedCrossRef
21.
go back to reference Krammer B, Plaetzer K. ALA and its clinical impact, from bench to bedside. Photochem Photobiol Sci. 2008;7(3):283–9.PubMedCrossRef Krammer B, Plaetzer K. ALA and its clinical impact, from bench to bedside. Photochem Photobiol Sci. 2008;7(3):283–9.PubMedCrossRef
22.
go back to reference Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, ALA-Glioma Study Group. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol. 2006;7(5):392–401.PubMedCrossRef Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, ALA-Glioma Study Group. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol. 2006;7(5):392–401.PubMedCrossRef
Metadata
Title
Photodynamic detection and management of intraperitoneal spreading of primary peritoneal papillary serous carcinoma in a man: report of a case
Authors
Emel Canbay
Haruaki Ishibashi
Shouzou Sako
Toshiyuki Kitai
Eisei Nishino
Masamitsu Hirano
Akiyoshi Mizumoto
Yoshio Endo
Shun-ichiro Ogura
Yutaka Yonemura
Publication date
01-02-2014
Publisher
Springer Japan
Published in
Surgery Today / Issue 2/2014
Print ISSN: 0941-1291
Electronic ISSN: 1436-2813
DOI
https://doi.org/10.1007/s00595-013-0500-1

Other articles of this Issue 2/2014

Surgery Today 2/2014 Go to the issue